NEFL and nervous system disorder: Furthermore, neurofilament light (NF-L) is emerging as a promising biomarker of large calibre axonal injury in serum or cerebrospinal fluid (CSF)17–20 and occasionally also by MD9 in patients with a variety of neurological disorders.